Back to homepage

Haematology and Oncology

Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature

Authors: Luis Miguel Juárez-Salcedo MD, Diego Conde-Royo MD, Keina Quiroz-Cervantes MD, Samir Dalia MD

This article discusses the role of mAbs in follicular lymphoma and marginal zone lymphoma along with reviewing the current data about the use of biosimilar mAbs in these diseases.

More▸

Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management

Authors: Antonio Ruggiero MD, Palma Maurizi MD, Silvia Triarico MD, Michele Antonio Capozza MD, Stefano Mastrangelo MD, Giorgio Attinà MD

This paper describes two case studies of infants with multifocal infantile haemangiomatosis and hepatic involvement. A review of current therapeutic approaches is also presented.

More▸

Tumor lysis syndrome in childhood malignancies

Authors: Wing Lum Cheung MBBS, MRCPCH, Kam Lun Hon MBBS, MD (CUHK), FAAP, FCCM, Cheuk Man Fung MBChB, MRCPCH, Alexander KC Leung MBBS, FRCPC, FRCP (UK & Irel), FRCPCH, FAAP

This review provides an update on the current understanding, evaluation, and management of tumor lysis syndrome in childhood malignancies.

More▸

Combination checkpoint inhibitors for treatment of non-small-cell lung cancer: an update on dual anti-CTLA-4 and anti-PD-1/PD-L1 therapies

Authors: Sonam Puri MD, Michael Shafique MD

This review discusses the rationale, outcomes, and challenges of combination immune checkpoint blockade in non-small-cell lung cancer (NSCLC).

More▸

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment

Authors: Donata Galbiati MD, Stefano Cavalieri MD, Salvatore Alfieri MD, Carlo Resteghini MD, Cristiana Bergamini MD, Ester Orlandi MD, Francesca Platini MD, Laura Locati MD, Luca Giacomelli PhD, Lisa Licitra MD, Paolo Bossi MD

This retrospective study aimed to review outcomes in patients with non-curable cutaneous squamous cell cancers treated with platinum-based chemotherapy and cetuximab.

More▸